Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis

NCT06818279 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Portal Vein Thrombosis
Liver Cirrhosis

Interventions

DRUG: Dabigatran
DRUG: Enoxaparin

Sponsor

Institute of Liver and Biliary Sciences, India